Research location
Beachwood
Ohio, United States
Advertisement
Research activity in Beachwood
Ohio, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 241 trials and 256 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Beachwood
241 linked trials · page 3 of 5Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN StudyNCT02488720 · 2015-09-08 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerNCT02488967 · 2015-07-26 · 2 site observations
ACTIVE_NOT_RECRUITING
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)NCT02371980 · 2015-02-10 · 1 site observation
COMPLETED
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesNCT02785913 · 2014-11-01 · 2 site observations
COMPLETED
Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02965378 · 2014-10-01 · 2 site observations
COMPLETED
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02785939 · 2014-09-01 · 2 site observations
COMPLETED
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerNCT02186847 · 2014-08-01 · 1 site observation
COMPLETED
Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersNCT02766335 · 2014-07-31 · 2 site observations
COMPLETED
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung CancerNCT02154490 · 2014-07-08 · 2 site observations
COMPLETED
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker MatchesNCT02926638 · 2014-06-16 · 1 site observation
TERMINATED
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast CancerNCT02137837 · 2014-05-01 · 1 site observation
TERMINATED
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 StudyNCT02158546 · 2014-05-01 · 1 site observation
COMPLETED
A Long-Term Safety Study of ALKS 5461NCT02141399 · 2014-05-01 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)NCT02079909 · 2014-03-01 · 1 site observation
COMPLETED
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossNCT02008357 · 2014-02-28 · 1 site observation
COMPLETED
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNCT01901094 · 2014-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerNCT01949337 · 2014-01-22 · 1 site observation
UNKNOWN
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)NCT01767909 · 2014-01-08 · 1 site observation
COMPLETED
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 2 site observations
ACTIVE_NOT_RECRUITING
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryNCT01872975 · 2013-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
trūFreeze® Spray Cryotherapy Patient RegistryNCT01802203 · 2013-04-01 · 1 site observation
COMPLETED
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerNCT01622868 · 2012-12-06 · 2 site observations
COMPLETED
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's DiseaseNCT01677572 · 2012-10-05 · 1 site observation
TERMINATED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01716975 · 2012-10-01 · 1 site observation
COMPLETED
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)NCT01688037 · 2012-09-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
Resveratrol for Alzheimer's DiseaseNCT01504854 · 2012-05-01 · 1 site observation
COMPLETED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's DiseaseNCT01560585 · 2012-04-01 · 1 site observation
TERMINATED
Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderNCT01564862 · 2012-04-01 · 1 site observation
COMPLETED
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentNCT01457677 · 2011-12-01 · 1 site observation
COMPLETED
A Long-Term Safety Study of Pomaglumetad Methionil in SchizophreniaNCT01487083 · 2011-12-01 · 1 site observation
TERMINATED
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes ControlNCT01323348 · 2011-10-01 · 1 site observation
COMPLETED
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)NCT01360866 · 2011-10-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)NCT01432457 · 2011-10-01 · 1 site observation
COMPLETED
A Study in Patients With Type 2 DiabetesNCT01408095 · 2011-09-01 · 1 site observation
WITHDRAWN
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)NCT01312922 · 2011-09-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01361555 · 2011-08-01 · 1 site observation
TERMINATED
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerNCT01368588 · 2011-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01369095 · 2011-07-01 · 1 site observation
COMPLETED
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's DiseaseNCT01397539 · 2011-06-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)NCT01360632 · 2011-06-01 · 1 site observation
COMPLETED
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01435759 · 2011-05-31 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.